When should children with HIV infection be started on antiretroviral therapy?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18366251.
- Also identified by DOI 10.1371/journal.pmed.0050073 and PMC identifier 2270305.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The advent of highly active antiretroviral therapy (HAART) dramatically improved the prognosis for both adults and children infected with HIV who had access to treatment. However, the optimal timing for initiating treatment remains controversial, particularly in children. This debate lays out the case for deferred treatment against the case for early initiation of HAART in children.
Medical subject headings
- Anti-Retroviral Agents
- HIV Infections